March 23, 2020 / 1:53 PM / 8 days ago

BRIEF-Aytu Bioscience Received Confirmation From U.S. FDA That Co May Begin Distribution Of Its Coronavirus Disease 2019 IGG/IGM Rapid Test Throughout U.S.

March 23 (Reuters) - Aytu BioScience Inc:

* AYTU BIOSCIENCE - RECEIVED CONFIRMATION FROM U.S. FDA THAT CO MAY BEGIN DISTRIBUTION OF ITS CORONAVIRUS DISEASE 2019 IGG/IGM RAPID TEST THROUGHOUT U.S.

* AYTU BIOSCIENCE - COVID-19 IGG/IGM RAPID TEST IS INTENDED FOR PROFESSIONAL USE AND DELIVERS RESULTS BETWEEN 2 AND 10 MINUTES AT THE POINT-OF-CARE.

* AYTU BIOSCIENCE - IN ADDITION, COMPANY EXPECTS DELIVERY OF ITS FIRST SHIPMENT OF 100,000 TESTS THIS WEEK Source text: (bit.ly/2xXo8hm) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below